AR101222A1 - Derivados de piridona - Google Patents
Derivados de piridonaInfo
- Publication number
- AR101222A1 AR101222A1 ARP150102265A ARP150102265A AR101222A1 AR 101222 A1 AR101222 A1 AR 101222A1 AR P150102265 A ARP150102265 A AR P150102265A AR P150102265 A ARP150102265 A AR P150102265A AR 101222 A1 AR101222 A1 AR 101222A1
- Authority
- AR
- Argentina
- Prior art keywords
- carbon atoms
- alkyl
- phenyl
- heteroaryl
- cyclohexyl
- Prior art date
Links
- 125000004432 carbon atom Chemical group C* 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Abstract
Reivindicación 1: Un compuesto de la fórmula (1), en donde: R¹ es fenilo opcionalmente sustituido por uno a cuatro sustituyentes seleccionados a partir de alquilo de 1 a 3 átomos de carbono, halógeno, o -CH₂CH₂CH₂O-, en donde este grupo está enlazado a los átomos de carbono adyacentes sobre el fenilo para formar un anillo; L es un enlace, alquileno de 1 a 3 átomos de carbono, -SO₂-, -SO₂CH₂-, -NHSO₂-, -NHSO₂CH₂-, -C(O)-, -C(O)NH-, -C(O)NHCH₂-, -C(O)OCH₂-, -C(O)C(O)-, -CH₂C(O)-, heteroarilo de 3 a 7 átomos de carbono, o -heteroarilo de 3 a 7 átomos de carbono-NH-, en donde cada heteroarilo comprende de uno a tres heteroátomos seleccionados a partir de S, N, y O; R² es H, ciclohexilo, o fenilo, en donde el ciclohexilo y fenilo están opcionalmente sustituidos por uno a tres sustituyentes seleccionados a partir de alquilo de 1 a 3 átomos de carbono y halógeno; R³ es H o -NHSO₂R⁴, en donde R⁴ es alquilo de 1 a 8 átomos de carbono, y en donde este alquilo puede incluir porciones de cicloalquilo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462026782P | 2014-07-21 | 2014-07-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR101222A1 true AR101222A1 (es) | 2016-11-30 |
Family
ID=53718072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150102265A AR101222A1 (es) | 2014-07-21 | 2015-07-16 | Derivados de piridona |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9802898B2 (es) |
| EP (1) | EP3172189A1 (es) |
| JP (1) | JP2017521455A (es) |
| KR (1) | KR20170032324A (es) |
| CN (1) | CN106536482A (es) |
| AR (1) | AR101222A1 (es) |
| AU (1) | AU2015293578B2 (es) |
| CA (1) | CA2954724A1 (es) |
| CL (1) | CL2017000151A1 (es) |
| IL (1) | IL249560A0 (es) |
| MA (1) | MA40220A (es) |
| RU (1) | RU2016151973A (es) |
| TW (1) | TW201617317A (es) |
| UY (1) | UY36217A (es) |
| WO (1) | WO2016012913A1 (es) |
| ZA (1) | ZA201608598B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018020357A1 (en) | 2016-07-25 | 2018-02-01 | Viiv Healthcare Uk Limited | Indoline derivatives |
| JP7168556B2 (ja) | 2017-04-10 | 2022-11-09 | 三井化学アグロ株式会社 | ピリドン化合物およびそれを有効成分とする農園芸用殺菌剤 |
| US10293012B2 (en) | 2017-05-04 | 2019-05-21 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods of using extracts of melissa officinalis against filoviruses |
| WO2018208739A1 (en) * | 2017-05-08 | 2018-11-15 | Thomas Cahill | Pharmaceutical compositions comprising caffeic acid chelates |
| JP7157738B2 (ja) * | 2017-06-08 | 2022-10-20 | 三井化学アグロ株式会社 | ピリドン化合物およびそれを有効成分とする農園芸用殺菌剤 |
| EP3828177B1 (en) | 2018-07-25 | 2023-11-29 | Mitsui Chemicals Crop & Life Solutions, Inc. | Pyridone compound and agricultural and horticultural fungicide having this as active component |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2004002050A1 (es) * | 2003-08-13 | 2005-06-03 | Pharmacia Corp Sa Organizada B | Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros. |
| US7939545B2 (en) * | 2006-05-16 | 2011-05-10 | Boehringer Ingelheim International Gmbh | Inhibitors of human immunodeficiency virus replication |
| US8338441B2 (en) * | 2009-05-15 | 2012-12-25 | Gilead Sciences, Inc. | Inhibitors of human immunodeficiency virus replication |
| GB0913636D0 (en) * | 2009-08-05 | 2009-09-16 | Univ Leuven Kath | Novel viral replication inhibitors |
| WO2013002357A1 (ja) * | 2011-06-30 | 2013-01-03 | 塩野義製薬株式会社 | Ｈｉｖ複製阻害剤 |
| WO2013043553A1 (en) * | 2011-09-22 | 2013-03-28 | Glaxosmithkline Llc | Pyrrolopyridinone compounds and methods for treating hiv |
| ES2647437T3 (es) * | 2012-07-12 | 2017-12-21 | Viiv Healthcare Uk Limited | Compuestos y procedimientos para tratar el VIH |
-
2015
- 2015-07-16 AR ARP150102265A patent/AR101222A1/es unknown
- 2015-07-16 US US15/326,070 patent/US9802898B2/en not_active Expired - Fee Related
- 2015-07-16 AU AU2015293578A patent/AU2015293578B2/en not_active Ceased
- 2015-07-16 WO PCT/IB2015/055385 patent/WO2016012913A1/en active Application Filing
- 2015-07-16 MA MA040220A patent/MA40220A/fr unknown
- 2015-07-16 RU RU2016151973A patent/RU2016151973A/ru not_active Application Discontinuation
- 2015-07-16 KR KR1020177002216A patent/KR20170032324A/ko unknown
- 2015-07-16 JP JP2017503126A patent/JP2017521455A/ja not_active Ceased
- 2015-07-16 TW TW104123125A patent/TW201617317A/zh unknown
- 2015-07-16 EP EP15741363.4A patent/EP3172189A1/en not_active Withdrawn
- 2015-07-16 CN CN201580039443.4A patent/CN106536482A/zh active Pending
- 2015-07-16 CA CA2954724A patent/CA2954724A1/en not_active Abandoned
- 2015-07-16 UY UY0001036217A patent/UY36217A/es not_active Application Discontinuation
-
2016
- 2016-12-13 ZA ZA2016/08598A patent/ZA201608598B/en unknown
- 2016-12-14 IL IL249560A patent/IL249560A0/en unknown
-
2017
- 2017-01-19 CL CL2017000151A patent/CL2017000151A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2015293578B2 (en) | 2017-10-05 |
| UY36217A (es) | 2016-02-29 |
| CA2954724A1 (en) | 2016-01-28 |
| KR20170032324A (ko) | 2017-03-22 |
| US9802898B2 (en) | 2017-10-31 |
| TW201617317A (zh) | 2016-05-16 |
| WO2016012913A1 (en) | 2016-01-28 |
| CN106536482A (zh) | 2017-03-22 |
| JP2017521455A (ja) | 2017-08-03 |
| US20170217890A1 (en) | 2017-08-03 |
| MA40220A (fr) | 2017-05-31 |
| RU2016151973A3 (es) | 2018-11-09 |
| RU2016151973A (ru) | 2018-08-22 |
| CL2017000151A1 (es) | 2017-07-28 |
| AU2015293578A1 (en) | 2017-01-19 |
| EP3172189A1 (en) | 2017-05-31 |
| IL249560A0 (en) | 2017-02-28 |
| ZA201608598B (en) | 2019-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR101222A1 (es) | Derivados de piridona | |
| AR119651A1 (es) | Compuestos heterocíclicos y de heteroarilo para tratar la enfermedad de huntington | |
| CY1124537T1 (el) | Παραγωγο πυριδονης που εχει τετραϋδροπυρανυλ μεθυλ ομαδα | |
| AR110400A1 (es) | Compuestos de amino-triazolopiridina y su uso en el tratamiento del cáncer | |
| AR101815A1 (es) | Compuestos y composiciones como inhibidores de quinasa | |
| AR103742A1 (es) | Derivados de trifluorometilpropanamida | |
| AR098912A1 (es) | Inhibidores de syk | |
| AR094299A1 (es) | Derivados de ftalazin-1(2h)-ona sustituidos | |
| AR077695A1 (es) | Derivados de pirimidina como inhibidores del factor ixa | |
| EA201591486A1 (ru) | Соединения имидазопиридина | |
| AR091519A1 (es) | Inhibidores pirrolopirazona de tanquirasa | |
| AR101255A1 (es) | Derivados de isoindolinona | |
| CY1117688T1 (el) | Ενωσεις τετραϋδροπυρρολοθειαζινης | |
| CY1121626T1 (el) | Νεο παραγωγο υδροξαμικου οξεος ή αλας αυτου | |
| AR105549A1 (es) | Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos | |
| AR080703A1 (es) | Derivados de 3-(heteroaril-amino)-1,2,3,4-tetrahidro-9h-carbazol, moduladores de receptores de prostaglandina d2, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos alergicos o inmunitarios tales como asma. | |
| AR097253A1 (es) | Derivado de pirazolilpirazol sustituido y el uso del mismo como herbicida | |
| AR089753A1 (es) | Derivados de amida heterociclicos como antagonistas del receptor p2x7 | |
| AR089623A1 (es) | Inhibidores de iap | |
| AR106185A1 (es) | Compuestos macrocíclicos de sulfondiimina | |
| AR097252A1 (es) | Derivado de pirazolilpirazol sustituido y el uso del mismo como herbicida | |
| AR100439A1 (es) | Derivados de carboxamida | |
| AR097245A1 (es) | Derivado de pirazolilpirazol sustituido y su empleo como herbicida | |
| AR098713A1 (es) | 4-amino-6-(halo-alquil-sustituido)-picolinatos y su uso como herbicidas | |
| AR099475A1 (es) | Espiro-oxazolonas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |